Wells Fargo’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Wells Fargo’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,400	Closed	-$711	–	7302
2024 Q3	$711	Buy	+3,400	New	+$1.09K	﹤0.01%	6148
2024 Q2	–	Sell	-175	Closed	-$151	–	7619
2024 Q1	$151	Buy	+175	New	+$120	﹤0.01%	6569
2022 Q4	–	Sell	-350	Closed	–	–	7798
2022 Q3	$0	Hold	350	–	–	﹤0.01%	7581
2022 Q2	$1K	Hold	350	–	–	﹤0.01%	6659
2022 Q1	$2K	Hold	350	–	–	﹤0.01%	6712
2021 Q4	$6K	Hold	350	–	–	﹤0.01%	6686
2021 Q3	$7K	Hold	350	–	–	﹤0.01%	6310
2021 Q2	$11K	Hold	350	–	–	﹤0.01%	6124
2021 Q1	$9K	Buy	+350	New	+$8.77K	﹤0.01%	6384

Other funds holding RNLX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

IIC

Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return

Wells Fargo's RNLX Position: Q4 2024 in Review

Wells Fargo sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 3,400 shares — an estimated $711 sold.

Wells Fargo first reported a position in RNLX in Q1 2021 and held it in 9 quarters. The position peaked at $11K in Q2 2021. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

Wells Fargo reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Wells Fargo sold 3,400 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $711.
Wells Fargo first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 9 quarters.
Wells Fargo's Renalytix plc American Depositary Shares position peaked at $11K in Q2 2021.
3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.